Outline of patents

AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States

Intellectual property law, Monopoly, Patent, Genetic engineering in the United States, Patent law, Outline of patents

The new patent covers novel medical device structures, methods, and biophysical related test parameters for improved detection performance.

Key Points: 
  • The new patent covers novel medical device structures, methods, and biophysical related test parameters for improved detection performance.
  • The newly granted patent this week brings the total number of issued and granted AnPac Bio patents to nineteen in the United States.
  • AnPac Bio has always focused on technological innovation and building a strong patent and IP portfolio in the space of cancer screening and detection.
  • AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 121 granted patents as of December 31, 2019.

Grant of European Patent for ColdZyme

Retrieved on: 
Tuesday, May 19, 2020
Law by country, Intellectual property law, Politics by country, European Patent Organisation, Patent law, European patent law, Patent application, Patent, European Patent Convention, European Patent Office, Outline of patents, Patent prosecution

STOCKHOLM, May 19, 2020 /PRNewswire/ -- The European Patent Office has granted Enzymatica's patent for the key cod enzyme component of Enzymatica's cold spray ColdZyme for the European market.

Key Points: 
  • STOCKHOLM, May 19, 2020 /PRNewswire/ -- The European Patent Office has granted Enzymatica's patent for the key cod enzyme component of Enzymatica's cold spray ColdZyme for the European market.
  • Enzymatica announced on February 3 that the European Patent Office intended to grant a patent for the cod enzyme, which is one of the key components of ColdZyme.
  • Enzymatica has developed an improved cod enzyme formulation for ColdZyme, for which new patent applications were globally filed in 2015 (European patent application number 16745663.1).
  • The latest European patent is derived from this new patent family.

InMed Files PCT Patent Application for Neuroprotection in Glaucoma

Retrieved on: 
Tuesday, May 12, 2020
Law by country, Politics by country, Monopoly, Patent, European patent law, European Patent Organisation, Outline of patents, European Patent Convention

The patent application, entitled "Compositions and Methods for Use of Cannabinoids for Neuroprotection" represents an important step in protecting the Company's intellectual property and commercial opportunities.

Key Points: 
  • The patent application, entitled "Compositions and Methods for Use of Cannabinoids for Neuroprotection" represents an important step in protecting the Company's intellectual property and commercial opportunities.
  • Currently approved glaucoma therapies are typically intended to decrease intraocular pressure, which may lead to an indirect effect of reducing neuron damage in the eye.
  • The PCT is an international patent law treaty, which provides a unified procedure for filing patent applications to protect inventions in each of its member states.
  • There are 151 member countries within the PCT, enabling near-global patent coverage through successful patent prosecution in the U.S., Japan, Europe, Canada, Australia, New Zealand, China, Brazil, Russia, India, as well as many others.

Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd®

Retrieved on: 
Friday, April 24, 2020
Intangible assets, Monopoly, Patent, Pharmaceutical industry, Health, Articles, Outline of patents

"Having this patent granted in Japan is an important addition to our IP portfolio", says Ulf Hannelius, CEO of Diamyd Medical.

Key Points: 
  • "Having this patent granted in Japan is an important addition to our IP portfolio", says Ulf Hannelius, CEO of Diamyd Medical.
  • "Japan is one of the largest pharmaceutical markets in the world and the patent will increase our ability to enter into commercial partnerships for Diamyd".
  • Diamyd Medical already holds, as part of an exclusive license from the University of California, Los Angeles (UCLA), patent protection in the United States, which is valid until 2032 for the treatment of diabetes with GAD, the active component of the diabetes vaccine Diamyd.
  • In addition to the patent granted in Japan, Diamyd Medical holds patent protection in Europe for intralymphatic administration of Diamyd valid untl 2035.

Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd®

Retrieved on: 
Friday, April 24, 2020
Intangible assets, Monopoly, Patent, Pharmaceutical industry, Health, Articles, Outline of patents

"Having this patent granted in Japan is an important addition to our IP portfolio", says Ulf Hannelius, CEO of Diamyd Medical.

Key Points: 
  • "Having this patent granted in Japan is an important addition to our IP portfolio", says Ulf Hannelius, CEO of Diamyd Medical.
  • "Japan is one of the largest pharmaceutical markets in the world and the patent will increase our ability to enter into commercial partnerships for Diamyd".
  • Diamyd Medical already holds, as part of an exclusive license from the University of California, Los Angeles (UCLA), patent protection in the United States, which is valid until 2032 for the treatment of diabetes with GAD, the active component of the diabetes vaccine Diamyd.
  • In addition to the patent granted in Japan, Diamyd Medical holds patent protection in Europe for intralymphatic administration of Diamyd valid untl 2035.

Ping An Ranks 8th in 2019 International Patent Applications, Demonstrating Leading Position in Technology R&D

Retrieved on: 
Tuesday, April 21, 2020
Law by country, Politics by country, Patent law, Patent application, Patent Cooperation Treaty, Patent, Blockchain, Outline of patents, Computer programs and the Patent Cooperation Treaty

Ping An Technology's patent applications included 679 in artificial intelligence (AI), 58 in blockchain and 48 in cloud computing, demonstrating a leading position in technological research and development (R&D) and innovation.

Key Points: 
  • Ping An Technology's patent applications included 679 in artificial intelligence (AI), 58 in blockchain and 48 in cloud computing, demonstrating a leading position in technological research and development (R&D) and innovation.
  • By filing one international patent application under the PCT, patent applicants can simultaneously seek protection for an invention in 148 countries.
  • PCT international patent application is one of the major channels for innovative enterprises to develop their global patents portfolio.
  • As of 31 December 2019, Ping An had filed 3,680 PCT patent applications, including 1,278 related to AI, 139 related to blockchain and 223 in cloud computing.

Ping An Ranks 8th in 2019 International Patent Applications, Demonstrating Leading Position in Technology R&D

Retrieved on: 
Tuesday, April 21, 2020
Law by country, Politics by country, Patent application, Patent, Patent law, Patent offices, Outline of patents, Computer programs and the Patent Cooperation Treaty

Ping An Technology's patent applications included 679 in artificial intelligence (AI), 58 in blockchain and 48 in cloud computing, demonstrating a leading position in technological research and development (R&D) and innovation.

Key Points: 
  • Ping An Technology's patent applications included 679 in artificial intelligence (AI), 58 in blockchain and 48 in cloud computing, demonstrating a leading position in technological research and development (R&D) and innovation.
  • By filing one international patent application under the PCT, patent applicants can simultaneously seek protection for an invention in 148 countries.
  • PCT international patent application is one of the major channels for innovative enterprises to develop their global patents portfolio.
  • Ping An also ranked 40th in the 2019 WPP Millward Brown BrandZTM Top 100 Most Valuable Global Brands list.

Inventiv Develops Free Provisional Patent Application Software Tools to Help Inventors

Retrieved on: 
Saturday, April 4, 2020
Patent law, Provisional application, United States patent law, Patent, Human behavior, Invention, Humans, Articles, Outline of patents

Rather, those who can raise funding and get to market quicker have often benefited from the original inventor's hard work.

Key Points: 
  • Rather, those who can raise funding and get to market quicker have often benefited from the original inventor's hard work.
  • According to Jack Young, "Inventiv provides great help to an underserved community who could not afford expensive patent lawyers.
  • Resources provided at Inventiv.org includes free software on provisional patent application filing and a wealth of how-to videos such as how to patent an idea or product, what is a patent, how to search patents, how to check for patents, and how to file a patent, among others.
  • The free provisional filing software, video , and other resources are constantly updated by volunteers interested in improving access to our patent system by innovative start-ups, small companies, and individuals.

L&L Candle Company's ITC Complaint Against Infringing Manufacturers Moves Forward

Retrieved on: 
Thursday, April 2, 2020
Intellectual property law, Intangible assets, Monopoly, Patent law, Perkins Coie, Patent, Intellectual property, Lerner, David, Littenberg, Krumholz & Mentlik, Outline of patents

In the same manner, L&L expects others to respect its own intellectual property rights.

Key Points: 
  • In the same manner, L&L expects others to respect its own intellectual property rights.
  • L&L has a patent portfolio of hundreds of patents and patent applications worldwide to protect it and its innovations.
  • Founded in 1912, Perkins Coie LLP has more than 1,000 lawyers in 19 offices across the United States and Asia.
  • The firm provides a full array of corporate, commercial litigation and intellectual property legal services to a broad range of clients.

US Patent Practice | London, United Kingdom - June 11-12, 2020 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 17, 2020
Legal, Professional services, Law by country, Politics by country, Law, European Patent Organisation, Patent law, Law in the United Kingdom, Patent attorney, Patent, United States patent law, European Patent Convention, Outline of patents, Patent prosecution

The "US Patent Practice" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Patent Practice" conference has been added to ResearchAndMarkets.com's offering.
  • This highly interactive seminar will give you a comprehensive understanding of the US patent system and enable you to work more effectively with your US counterparts.
  • It will highlight the important differences between US and European patent practice and provide you with the opportunity for in-depth discussions about prosecution practice and procedure throughout the two days.
  • Offering a wide-ranging and detailed understanding, this seminar covers what every European patent practitioner should know about US patent practice.